# Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy

> **NCT01586767** · NA · UNKNOWN · sponsor: **Massachusetts General Hospital** · enrollment: 45 (actual)

## Conditions studied

- Adenoid Cystic Carcinoma
- Squamous Cell Carcinoma
- Sinonasal Carcinoma
- Sinonasal Undifferentiated Carcinoma
- Mucoepidermoid Carcinoma
- Schneiderian Carcinoma
- Myoepithelial Carcinoma
- Esthesioneuroblastoma
- Melanoma

## Interventions

- **RADIATION:** Proton radiation therapy
- **RADIATION:** Intensity-modulated radiotherapy

## Key facts

- **NCT ID:** NCT01586767
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-07-12
- **Primary completion:** 2022-10-17
- **Final completion:** 2025-11
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2023-09-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01586767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01586767, "Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01586767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*